Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Q Fever Vaccine NDBR 105
NCT02092142Phase 2Withdrawn
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Feb 2006
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
A Phase 2 trial of q fever vaccine in Q fever, sponsored by U.S. Army Medical Research and Development Command. Planned start Feb 2006; status: withdrawn.
02
Drugs
q fever vaccine
03
Conditions
Q fever
Beyond the preview
Go deeper on NCT02092142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02092142.